PLG-0206

N/A

Report date: 2026/02/14 20:00:22

NMEQIDP

Base Information

Drug NamePLG-0206

Drug Alias NamePLG-0206WLBU2

ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs > Antibiotics

Mechanisms of ActionCell membrane permeability enhancersCell membrane structures modulatorsBacterial biofilms inhibitors

TargetsUpdating

Therapy Area/IndicationsJoint DiseasesProsthesis-Related InfectionsInfections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesPeptilogics Inc

China Registration ClassN/A

Active CompaniesPeptilogics Inc

Inactive CompaniesN/A

Active IndicationsJoint DiseasesProsthesis-Related InfectionsInfections

Inactive IndicationsN/A

ATC CodeN/A